期刊文献+

类固醇生成因子-1在醛固酮瘤中的表达及意义 被引量:2

Expression and significance of steroidogenic factor-1 in aldosterone-producing adenoma OUY
原文传递
导出
摘要 目的 探讨类固醇生成因子-1(SF-1)在原发性醛固酮增多症(PA)发病中的作用.方法 分别收集16例醛固酮瘤组织标本和12例正常肾上腺组织标本,Western b1ot法检测各标本SF-1蛋白表达水平,荧光定量聚合酶链反应(PCR)法检测其mRNA表达水平.结果 醛固酮瘤组SF-1无论在蛋白表达水平还是在mRNA表达水平均高于正常肾上腺组,蛋白表达水平分别为(0.87±0.05和0.39±0.07,P<0.01),mRNA水平则前者是后者的10.48倍(P<0.01),差异均有统计学意义.结论 SF-1表达上调在PA的发病中发挥着重要作用. Objective To explore the effect of steroidogenic factor-1 ( SF-1 ) on the pathogenesis of primary aldosteronism (PA). Methods Sixteen aldosteronoma and twelve normal adrenal gland specimens were collected. Western blotting and real-time polymerase chain reaction (PCR) were used to detect the protein and mRNA expression of two groups, respectively. Results No matter in protein or mRNA level, the contents of SF-1 in aldosteronoma group were higher than that in normal adrenal gland group. Protein expression were 0. 87 ± 0. 05 and 0. 39 ± 0. 07 ( P 〈 0. 01 ). In mRNA expression level, the former was 10. 48 times higher than that of the latter ( P 〈 0. 01 ). There was significant difference between the two groups. Conclusion The up-regulation of SF-1 playsan important role in PA, and it may be become as a molecular target to study the pathogenesis of PA.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2010年第11期1722-1724,共3页 Chinese Journal of Experimental Surgery
基金 国家杰出青年科学基金(30725040)
关键词 类固醇生成因子-1 原发性醛固酮增多症 肾上腺 Steroidogenic factor-l Primary aldosteronism Adrenal
  • 相关文献

同被引文献10

  • 1Stewart PM.Mineralocorticoid hypertension.Lancet,1999,353:1341-1347.
  • 2Milliez P,Girerd X,Plouin PF,et al.Evidence for an increased rate ofcardiovascular events in patients with primary aldosteronism.J AmCoII Cardiol,2005,45:1243-1248.
  • 3Gard PR.The role of angiotensin II in cognition and behaviour.Eur JPharmacol,2002,438:1-14.
  • 4Massien-Simon C,Battaglia C,Chatellier G,et al.Conn1 s adenoma.Diagnostic and prognostic value of the measurement of potassium,re-nin,aldosterone levels and the aldosterone/renin ratio.Presse Med,1995,24:1238-1242.
  • 5Morris DG, Kola B, Borboli N, et al. Identi- fication of adrenocortieotropin receptor messenger ribonueleie acid in the haman pituitary and its loss of expression in pitui- tary adenomas [ J ]. J Clin Endocrinol Metab,2003,88 ( 12 ) : 6080-6087.
  • 6Schimmer BP, White PC. Steroidogenic factor-1 :its roles in differentiation, devel- opment and disease [ J ]. Mol Endocrinol, 2010,24(7 ) : 1322-1337.
  • 7Weber A,Toppari J,Harvey RD,et al. Ad- renocorticotropin receptor gene mutations in familial glueocmticoid deficiency: rela- tionships with clinical features in four fam- ilies[ J ]. J Clin Endocrinol Metab, 1995, 80( 1 ) :65-71.
  • 8Mountjoy KG, Bird IM, Rainey WE, et al. ACTH induces up-regulation of ACTH re- ceptor mRNA in mouse and human adreno- cortical cell lines [ J]. Mol Cell Endoeri- nol, 1994,99 ( 1 ) : R17-R20.
  • 9胡东亮,欧阳金芝,马鑫,李宏召,王保军,史涛坪,王少刚,张旭.类固醇生成因子-1基因沉默对人肾上腺皮质腺癌H295R细胞的作用及其临床意义[J].中华泌尿外科杂志,2010,31(8):524-528. 被引量:3
  • 10胡东亮,欧阳金芝,王保军,马鑫,李宏召,史涛坪,吴准,闫永吉,李俊,王少刚,张旭.类固醇生成因子-1基因沉默在介导血管紧张素Ⅱ对醛固酮分泌调控的影响[J].中华实验外科杂志,2010,27(10):1507-1510. 被引量:3

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部